Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas
Botensilimab(Fc增强型抗细胞毒性淋巴细胞相关蛋白-4抗体)联合Balstilimab(抗PD-1抗体)治疗复发/难治性转移性肉瘤患者
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-24-02524
Wilky, Breelyn A; Schwartz, Gary K; Gordon, Michael S; El-Khoueiry, Anthony B; Bullock, Andrea J; Henick, Brian; Agulnik, Mark; Singh, Arun; Mahadevan, Daruka; Stebbing, Justin; Delepine, Chloe; Chand, Dhan; Avagyan, Manushak; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven; Trent, Jonathan C; Jones, Robin L; Tsimberidou, Apostolia M